Third quarter SaaS revenue of $60.9 million, representing 45% year-over-year growth Third quarter Total revenue of $88.8 million, representing 22% year-over-year growth Total ARR of $308.9 million, representing 23% year-over-year growth JERSEY CITY, N.J., …
REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in investor meetings at the …
— Revenue Increased 5% — — Repurchased $210 Million of Shares — — Reaffirms Full Year Outlook — KANSAS CITY, Mo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the "Company") today released financial results1 for its fiscal …
Prioritize and focus resources on LNCB74 (B7-H4 ADC) with a planned IND submission by year-end Cash of approximately $75 million expected to fund operations into second half of 2026 BELTSVILLE, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: …
Reports Q3 2024 Net Revenues Increase of 13.1% vs. Q3 2023 Reiterates Fiscal Year 2024 Net Revenue Guidance of Between RMB233 Million and RMB255 Million Conference Call Scheduled for Thursday, November 7, at 8:00 p.m. Eastern Time (Friday, November 8, at 9 …
MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- November 7, 2024 (GLOBE NEWSWIRE) – Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Wolfe Research Wealth Symposium on Wednesday, …
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott …
Topline SVR12 Results from Global Phase 2 Hepatitis C Virus (HCV) Study (N=275) Expected Q4’24 New Data Supportive of HCV Combination to be Presented at the American Association for the Study of Liver Diseases’ (AASLD’s) The Liver Meeting 2024 …
Preliminary data demonstrate durable and dose-dependent T cell responses targeting KRAS mutations and induced responses to patient-specific neoantigens Correlation observed between disease-free survival (“DFS”) and T cell response ELI-002 Phase 1 safety …
Q1’25 Financial Results and Recent Business Highlights Revenue of $257.7 million GAAP gross margin of 46.9 percent Non-GAAP gross margin of 53.9 percent GAAP loss per share of $0.58 Non-GAAP diluted earnings per share of $0.81 SAN JOSE, Calif., Nov. 07, …
PENNSAUKEN, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty health …
Delivered Net Sales Within Guidance Range and Drove 11% Year-Over-Year Repeat Order Growth Increased Third Quarter Gross Margin by 230 bps Year-Over-Year to 60.8% Reported GAAP Diluted EPS of $(0.01) and Adjusted Diluted EPS of $0.02 Exceeded Profitability …
Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65% Record gross margin of 90.6%, up 300 basis points from the year-ago period Adjusted EBITDA increased 33% to $3.7 million Telehealth adjusted EBITDA of $2.5 million, …
BEACON-IPF Phase 2b trial on track for full enrollment in the first quarter of 2025 with data anticipated in mid-2026 SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage clinical …
LITTLE ROCK, Ark., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today reported financial results for the third quarter ended September 30, 2024. Scott T. Ford, CEO and Co-founder stated, “ …
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended …
MINNEAPOLIS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced financial results for its third quarter ended September 30, 2024, through an earnings release available on the company’ …
MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third …
SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended September 30, 2024. Financial Highlights: Q3 …
MINNEAPOLIS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (OTCQX: AATC) today announced results for its quarter and nine months ended September 30, 2024. Net income from continuing operations for the quarter ended September 30, 2024 …
02 days 10:22:25
